These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19236078)

  • 1. Molecular dendritic transporter nanoparticle vectors provide efficient intracellular delivery of peptides.
    Hamilton SK; Harth E
    ACS Nano; 2009 Feb; 3(2):402-10. PubMed ID: 19236078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo.
    Li YF; Morcos PA
    Bioconjug Chem; 2008 Jul; 19(7):1464-70. PubMed ID: 18564870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
    Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER
    Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides.
    Medintz IL; Pons T; Delehanty JB; Susumu K; Brunel FM; Dawson PE; Mattoussi H
    Bioconjug Chem; 2008 Sep; 19(9):1785-95. PubMed ID: 18681468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles.
    Kwon EJ; Bergen JM; Pun SH
    Bioconjug Chem; 2008 Apr; 19(4):920-7. PubMed ID: 18376855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles.
    Gaertner HF; Cerini F; Kamath A; Rochat AF; Siegrist CA; Menin L; Hartley O
    Bioconjug Chem; 2011 Jun; 22(6):1103-14. PubMed ID: 21574642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition.
    Borghouts C; Kunz C; Delis N; Groner B
    Mol Cancer Res; 2008 Feb; 6(2):267-81. PubMed ID: 18314488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of nanoparticle-cored dendrimers by convergent dendritic functionalization of monolayer-protected nanoparticles.
    Shon YS; Choi D; Dare J; Dinh T
    Langmuir; 2008 Jun; 24(13):6924-31. PubMed ID: 18507425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells.
    Koch AM; Reynolds F; Kircher MF; Merkle HP; Weissleder R; Josephson L
    Bioconjug Chem; 2003; 14(6):1115-21. PubMed ID: 14624624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide dendrimers as artificial enzymes, receptors, and drug-delivery agents.
    Darbre T; Reymond JL
    Acc Chem Res; 2006 Dec; 39(12):925-34. PubMed ID: 17176031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic oligoguanidines as intracellular translocators.
    Chung HH; Harms G; Seong CM; Choi BH; Min C; Taulane JP; Goodman M
    Biopolymers; 2004; 76(1):83-96. PubMed ID: 14997478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of surface-modified nanoparticles through cell monolayers.
    Koch AM; Reynolds F; Merkle HP; Weissleder R; Josephson L
    Chembiochem; 2005 Feb; 6(2):337-45. PubMed ID: 15651046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface thiols affect cell entry of disulfide-conjugated peptides.
    Aubry S; Burlina F; Dupont E; Delaroche D; Joliot A; Lavielle S; Chassaing G; Sagan S
    FASEB J; 2009 Sep; 23(9):2956-67. PubMed ID: 19403512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic molecular transporters provide control of delivery to intracellular compartments.
    Huang K; Voss B; Kumar D; Hamm HE; Harth E
    Bioconjug Chem; 2007; 18(2):403-9. PubMed ID: 17284011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA.
    Jiang S; Zhang Y; Lim KM; Sim EK; Ye L
    Nanotechnology; 2009 Apr; 20(15):155101. PubMed ID: 19420539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surface modification of silver nanoparticles by phosphoryl disulfides for improved biocompatibility and intracellular uptake.
    Chung YC; Chen IH; Chen CJ
    Biomaterials; 2008 Apr; 29(12):1807-16. PubMed ID: 18242693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle cellular uptake by dendritic wedge peptides: achieving single peptide facilitated delivery.
    Breger JC; Muttenthaler M; Delehanty JB; Thompson DA; Oh E; Susumu K; Deschamps JR; Anderson GP; Field LD; Walper SA; Dawson PE; Medintz IL
    Nanoscale; 2017 Jul; 9(29):10447-10464. PubMed ID: 28703833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein G system.
    Lim YT; Cho MY; Lee JM; Chung SJ; Chung BH
    Biomaterials; 2009 Feb; 30(6):1197-204. PubMed ID: 19056121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
    Gupte A; Wadhwa S; Mumper RJ
    Bioconjug Chem; 2008 Jul; 19(7):1382-8. PubMed ID: 18570451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.